Multiple sclerosis and fracture

International Journal of Neuroscience

Volumn 123, Issue 9, 2013, Pages 609-616

  Ye, Suhong ^a   Wu, Rendi ^a   Wu, Jie ^b  

^a JINHUA MUNICIPAL CENTRAL HOSPITAL   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Fracture; Multiple sclerosis; Osteoporosis; Review

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CALCIFEDIOL; GLUCOCORTICOID; METHYLPREDNISOLONE;

ARTICLE; BONE DENSITY; BONE TURNOVER; CORTICOSTEROID THERAPY; DISABILITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG MEGADOSE; EXPANDED DISABILITY STATUS SCALE; FALLING; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; LOW DRUG DOSE; META ANALYSIS (TOPIC); MORBIDITY; MULTIPLE SCLEROSIS; OSTEOLYSIS; OSTEOPOROSIS; PREVALENCE; RISK ASSESSMENT; SPINE FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WRIST FRACTURE;

DATABASES, BIBLIOGRAPHIC; DISABLED PERSONS; FRACTURES, BONE; HUMANS; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RISK;

EID: 84882307328     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.785950     Document Type: Article

References (51)

1. Moreira MA, Tilbery CP, Lana-Peixoto MA, et al. Aspectos histöricos de la esclerosis mültiple. Rev Neurol 2002;34: 378-83
2. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-31
3. Dua T, Romani P. Atlas multiple sclerosis resources in the World 2008. Available from: Http://www.who.int/mental health/ neurology/Atlas MS WEB.pdf [last accessed 26 Nov 2010].
4. Stenager E, Jensen K. Fracture in multiple sclerosis. Acta Neurol Belg 1991;91(5):296-302
5. Troiano RA, Jotkowitz A, Cook SD, et al. Rate and types of fracture in corticosteroid-Treated multiple sclerosis patients. Neurology 1992;42:1389-91
6. Logan WC Jr, Sloane R, Lyles KW, et al. Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury. Arch Phys Med Rehabil 2008;89(2):237-43
7. Bazelier MT, Van Staa TP, Uitdehaag BM, et al. The risk of fracture in patients with multiple sclerosis: The UK general practice research database. J Bone Miner Res 2011;26:2271
8. Gibson JC, Summers GD. Bone health inmultiple sclerosis.Osteoporos Int 2011;22:2935-49
9. Nilsag̊ard Y, Lundholm C, Denison E, Gunnarsson LG. Predicting accidental falls in people with multiple sclerosis: A longitudinal study. Clin Rehabil 2009;23:259-69
10. Sibley WA, Bamford CR, Clark K, et al. A prospective study of physical trauma and multiple sclerosis. J Neurol Neurosurg Psychiatry 1991;54:584-9
11. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis, diagnosis and therapy. JAMA 2001;285:785-95
12. Terzi T, Terzi M, Tander B, et al. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables. J Clin Neurosci 2010;17:1260-4
13. Kanis JA, Johansson H, Oden A, et al. A meta-Analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19(6):893-9
14. Marrie RA, Cutter G, Tyry T, Vollmer T. A crosssectional study of bone health in multiple sclerosis. Neurology 2009;73:1394-8
15. Cosman F, Nieves J, Komar L, et al. Fracture history and bone loss in patients with MS. Neurology 1998;51(4):1161-5
16. BazelierMT, Van Staa TP, Uitdehaag BM, et al. Risk of fracture in patients with multiple sclerosis: A population-based cohort study. Neurology 2012;78:1967-73
17. Bazelier MT, Bentzen J, Vestergaard P, et al. The risk of fracture in incident multiple sclerosis patients: TheDanishNational Health Registers. Mult Scler 2012;18(11):1609-16
18. Ramagopalan SV, Seminog O, Goldacre R, Goldacre MJ. Risk of fracture in patients with multiple sclerosis: Record-linkage study. BMC Neurology 2012;12:135
19. Dennison EM, Compston JE, Flahive J, et al. Effect of comorbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 2012;50:1288-93
20. Moen SM, Celius EG, Sandvik L, et al. Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome. Neurology 2011;77:151-7
21. Moen SM, Celius EG, Nordsletten L, Holm T. Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis. Acta Neurol Scand Suppl 2011;191:79-82
22. Weinstock-Guttman B, Gallagher E, Baier M, et al. Risk of bone loss in men with multiple sclerosis. Mult Scler 2004;10: 170-5
23. Zorzon M, Zivadinov R, Locatelli L, et al. Long-Term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol 2005;12:550-6
24. Dobson R, Ramagopalan1 S, Giovannoni G. Bone health and multiple sclerosis. Mult Scler J 2012;18(11):1522-8
25. Gibson JC, Summers GD. Bone health inmultiple sclerosis.Osteoporos Int 2011;22:2935-49
26. Epstein AM, Inzerillo J, Caminis M, Zaidi. Disorders associated with acute rapid and severe bone loss. J Bone Miner Res 2003;18(12):2083-94
27. Moen SM, Celius EG, Sandvik L, et al. Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: A population-based case-control study. PLoS One 2012;7(9):e45703
28. Sioka C, Papakonstantinou S, Fotopoulos A, et al. Bone mineral density in ambulatory patients with multiple sclerosis. Neurol Sci 2011;32:819-24
29. Weinstein RS. Glucocorticoid-induced osteoporosis. Rev Endocr Metab Disord 2001;2:65-73
30. Stepan JJ, Havrdova E, Tyblova M, et al. Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clin Chim Acta 2004;348:147-54
31. Schwid SR, Goodman AD, Puzas JE, et al. Sporadic corticosteroid pulses and osteoporosis inmultiple sclerosis. ArchNeurol 1996;53:753-7
32. Shiek Ahmad B, Hill KD, O'Brien TJ, et al. Falls and fracture in patients chronically treated with antiepileptic drugs. Neurology 2012;79:145-51
33. Verdel BM, Souverein PC, Egberts TCG, et al. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fracture. Bone 2010;47(3):604-9
34. Yuan FL, Li X, Lu WG, et al. Regulatory T cells as a potent target for controlling bone loss. Biochem Bioph Res Co 2010;402(2):173-6
35. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302
36. Peterson EW, Cho CC, Von KL, Finlayson ML. Injurious falls among middle aged and older adults with multiple sclerosis. Arch Phys Med Rehabil 2008;89:1031-7
37. Finlayson ML, Peterson EW, Cho CC. Risk factors for falling among people aged 45 to 90 years with multiple sclerosis. Arch Phys Med Rehabil 2006;87:1274-9
38. Nilsagard Y, Lundholm C, Denison E, Gunnarsson LG. Predicting accidental falls in people with multiple sclerosis-A longitudinal study. Clin Rehabil 2009;23:259-69
39. Matsuda PN, Shumway-Cook A, Ciol MA, et al. Understanding falls in multiple sclerosis: Association of mobility status, concerns about falling, and accumulated impairments. Phys Ther 2012;92:407-15
40. Matsuda PN, Shumway-Cook A, Bamer AM, et al. Falls in multiple sclerosis: Incidence, causes, risk factors and health care provider response. PMR 2011;3:624-32
41. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97
42. BazelierMT, van Staa TP, Uitdehaag BM, et al. A simple score for estimating the long-Termrisk of fracture in patients with multiple sclerosis. Neurology 2012;79(9):922-8
43. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52
44. US Department of Health and Human Services. Bone health and osteoporosis: A report of the surgeon general. US Department of Health and Human Services, Rockville; 2004
45. Heinonen A, Kannus P, Sievanen H, et al. Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 1996;348: 1343-7
46. Bolland MJ, Grey AB, Gamble GD, Reid IR. Effect of osteoporosis treatment on mortality: A meta-Analysis. J Clin Endocr Metab 2010;95(3):1174-81
47. Center JR, BliucD, Nguyen ND, et al. Osteoporosismedication and reduced mortality risk in elderly women and men. J Clin Endocr Metab 2011;96(4):1006-14
48. Sale JE, Beaton D, Posen J, et al. Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 2011;22:2067-82
49. Kampman MT, Eriksen EF, Holḿ T. Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications? Acta Neurol Scand Suppl 2011;191:44-9
50. Steffensen LH, Jøgensen L, Straume B, et al. Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol 2011;258(9): 1624-31
51. Gillespie WJ, Gillespie LD, Parker MJ. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2010;10:CD001255